SOLY - Soliton gets FDA 510k clearance for RESONIC device

Soliton (SOLY) announces that the U.S. FDA has given clearance for the company's special 510k for modifications to its RESONIC device, used in tattoo removal and cellulite treatment.The RESONIC device utilizes the RAP technology to deliver safe and effective tattoo removal and cellulite treatment and now includes an autoloading cartridge and an improved user interface.The modifications are geared towards providing for a more seamless user experience, the company said.Shares up more than 2% premarket.

For further details see:

Soliton gets FDA 510k clearance for RESONIC device